• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Rare genetic causes of complex kidney and urological diseases.罕见的遗传原因导致的复杂肾脏和泌尿系统疾病。
Nat Rev Nephrol. 2020 Nov;16(11):641-656. doi: 10.1038/s41581-020-0325-2. Epub 2020 Aug 17.
2
Personalized medicine in chronic kidney disease by detection of monogenic mutations.遗传性肾脏疾病的个体化医学:单基因突变检测。
Nephrol Dial Transplant. 2020 Mar 1;35(3):390-397. doi: 10.1093/ndt/gfz028.
3
Monogenic causes of chronic kidney disease in adults.成人慢性肾脏病的单基因病因。
Kidney Int. 2019 Apr;95(4):914-928. doi: 10.1016/j.kint.2018.10.031. Epub 2019 Feb 14.
4
Polygenic risk alters the penetrance of monogenic kidney disease.多基因风险改变单基因肾脏疾病的外显率。
Nat Commun. 2023 Dec 14;14(1):8318. doi: 10.1038/s41467-023-43878-9.
5
Polygenic risk affects the penetrance of monogenic kidney disease.多基因风险影响单基因肾病的外显率。
medRxiv. 2023 May 10:2023.05.07.23289614. doi: 10.1101/2023.05.07.23289614.
6
A Role for Genetic Modifiers in Tubulointerstitial Kidney Diseases.遗传修饰物在肾小管间质性肾脏疾病中的作用。
Genes (Basel). 2023 Aug 3;14(8):1582. doi: 10.3390/genes14081582.
7
Monogenic and polygenic concepts in chronic kidney disease (CKD).单基因和多基因概念在慢性肾脏病(CKD)中的应用。
J Nephrol. 2024 Jan;37(1):7-21. doi: 10.1007/s40620-023-01804-8. Epub 2023 Nov 21.
8
[THE GENETIC BASIS OF CHRONIC KIDNEY DISEASE IN CHILDREN AND YOUNG ADULTS].[儿童及青年慢性肾脏病的遗传基础]
Harefuah. 2021 Dec;160(12):839-846.
9
Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts.不完全显性与可变表达:从临床研究到人群队列
Front Genet. 2022 Jul 25;13:920390. doi: 10.3389/fgene.2022.920390. eCollection 2022.
10
Insights into kidney diseases from genome-wide association studies.从全基因组关联研究看肾脏疾病。
Nat Rev Nephrol. 2016 Sep;12(9):549-62. doi: 10.1038/nrneph.2016.107. Epub 2016 Aug 1.

引用本文的文献

1
Big data analytics and machine learning in hematology: Transformative insights, applications and challenges.血液学中的大数据分析与机器学习:变革性见解、应用及挑战
Medicine (Baltimore). 2025 Mar 7;104(10):e41766. doi: 10.1097/MD.0000000000041766.
2
Genetic kidney disease has a higher likelihood and cost of inpatient admissions compared to other aetiologies.与其他病因相比,遗传性肾病患者住院的可能性更高,费用也更高。
Genet Med Open. 2024 Jul 25;2:101876. doi: 10.1016/j.gimo.2024.101876. eCollection 2024.
3
The impact of the Turkish population variome on the genomic architecture of rare disease traits.土耳其人群变异组对罕见病性状基因组结构的影响。
Genet Med Open. 2024 Feb 14;2:101830. doi: 10.1016/j.gimo.2024.101830. eCollection 2024.
4
Identification of GTF2I Polymorphisms as Potential Biomarkers for CKD in the Han Chinese Population : Multicentric Collaborative Cross-Sectional Cohort Study.鉴定GTF2I基因多态性作为中国汉族人群慢性肾脏病潜在生物标志物:多中心协作横断面队列研究
Kidney360. 2024 Oct 1;5(10):1466-1476. doi: 10.34067/KID.0000000000000517. Epub 2024 Jul 18.
5
Monogenic Kidney Diseases in Adults With Chronic Kidney Disease (CKD).成人慢性肾脏病(CKD)中的单基因肾病
Dtsch Arztebl Int. 2024 Oct 18;121(21):689-695. doi: 10.3238/arztebl.m2024.0120.
6
Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study.司帕生坦3期双盲研究中局灶节段性肾小球硬化症患者的基线特征
Kidney Int Rep. 2024 Jan 28;9(4):1020-1030. doi: 10.1016/j.ekir.2024.01.032. eCollection 2024 Apr.
7
Ramipril therapy in integrin α1-null, autosomal recessive Alport mice triples lifespan: mechanistic clues from RNA-seq analysis.血管紧张素转换酶抑制剂雷米普利治疗整合素 α1 基因敲除的常染色体隐性遗传性 Alport 综合征小鼠可使其寿命延长两倍:RNA-seq 分析的机制线索。
J Pathol. 2024 Mar;262(3):296-309. doi: 10.1002/path.6231. Epub 2023 Dec 21.
8
Develop and Validate a Risk Score in Predicting Renal Failure in Focal Segmental Glomerulosclerosis.开发并验证预测局灶节段性肾小球硬化症肾衰竭的风险评分。
Kidney Dis (Basel). 2023 Mar 28;9(4):285-297. doi: 10.1159/000529773. eCollection 2023 Aug.
9
Frequency, morbidity and equity - the case for increased research on male fertility.频率、发病率和公平性——增加男性生育力研究的理由。
Nat Rev Urol. 2024 Feb;21(2):102-124. doi: 10.1038/s41585-023-00820-4. Epub 2023 Oct 12.
10
Chronic kidney disease in children: an update.儿童慢性肾脏病:最新进展
Clin Kidney J. 2023 Apr 24;16(10):1600-1611. doi: 10.1093/ckj/sfad097. eCollection 2023 Oct.

本文引用的文献

1
Genetic testing for kidney disease of unknown etiology.遗传性肾脏疾病病因不明的基因检测。
Kidney Int. 2020 Sep;98(3):590-600. doi: 10.1016/j.kint.2020.03.031. Epub 2020 Apr 24.
2
Human and mouse studies establish TBX6 in Mendelian CAKUT and as a potential driver of kidney defects associated with the 16p11.2 microdeletion syndrome.人类和小鼠研究确定了TBX6在孟德尔先天性肾脏和尿路畸形中的作用,并将其作为与16p11.2微缺失综合征相关的肾脏缺陷的潜在驱动因素。
Kidney Int. 2020 Oct;98(4):1020-1030. doi: 10.1016/j.kint.2020.04.045. Epub 2020 May 22.
3
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis.膜性肾病的遗传结构及其对改善非侵入性诊断的潜力。
Nat Commun. 2020 Mar 30;11(1):1600. doi: 10.1038/s41467-020-15383-w.
4
Variable prediction accuracy of polygenic scores within an ancestry group.群体内多基因评分的预测准确性存在差异。
Elife. 2020 Jan 30;9:e48376. doi: 10.7554/eLife.48376.
5
Collagen IV Gene Mutations in Adults With Bilateral Renal Cysts and CKD.双侧肾囊肿和慢性肾脏病成人患者的IV型胶原基因突变
Kidney Int Rep. 2019 Sep 11;5(1):103-108. doi: 10.1016/j.ekir.2019.09.004. eCollection 2020 Jan.
6
Reverse Phenotyping after Whole-Exome Sequencing in Steroid-Resistant Nephrotic Syndrome.全外显子测序在激素抵抗型肾病综合征中的反向表型研究。
Clin J Am Soc Nephrol. 2020 Jan 7;15(1):89-100. doi: 10.2215/CJN.06060519. Epub 2019 Dec 12.
7
Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases.下一代测序的靶向广泛基因检测为肾脏病患者的诊断和治疗提供了信息。
Nephrol Dial Transplant. 2021 Jan 25;36(2):295-305. doi: 10.1093/ndt/gfz173.
8
Polygenic burden in focal and generalized epilepsies.多基因负担在局灶性和全面性癫痫中的作用。
Brain. 2019 Nov 1;142(11):3473-3481. doi: 10.1093/brain/awz292.
9
Contribution of retrotransposition to developmental disorders.逆转座子对发育障碍的贡献。
Nat Commun. 2019 Oct 11;10(1):4630. doi: 10.1038/s41467-019-12520-y.
10
Genetic regulatory variation in populations informs transcriptome analysis in rare disease.群体遗传调控变异为罕见病的转录组分析提供信息。
Science. 2019 Oct 18;366(6463):351-356. doi: 10.1126/science.aay0256. Epub 2019 Oct 10.

罕见的遗传原因导致的复杂肾脏和泌尿系统疾病。

Rare genetic causes of complex kidney and urological diseases.

机构信息

Division of Nephrology, Columbia University College of Physicians and Surgeons, New York, NY, USA.

Institute for Genomic Medicine, Columbia University, New York, NY, USA.

出版信息

Nat Rev Nephrol. 2020 Nov;16(11):641-656. doi: 10.1038/s41581-020-0325-2. Epub 2020 Aug 17.

DOI:10.1038/s41581-020-0325-2
PMID:32807983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7772719/
Abstract

Although often considered a single-entity, chronic kidney disease (CKD) comprises many pathophysiologically distinct disorders that result in persistently abnormal kidney structure and/or function, and encompass both monogenic and polygenic aetiologies. Rare inherited forms of CKD frequently span diverse phenotypes, reflecting genetic phenomena including pleiotropy, incomplete penetrance and variable expressivity. Use of chromosomal microarray and massively parallel sequencing technologies has revealed that genomic disorders and monogenic aetiologies contribute meaningfully to seemingly complex forms of CKD across different clinically defined subgroups and are characterized by high genetic and phenotypic heterogeneity. Investigations of prevalent genomic disorders in CKD have integrated genetic, bioinformatic and functional studies to pinpoint the genetic drivers underlying their renal and extra-renal manifestations, revealing both monogenic and polygenic mechanisms. Similarly, massively parallel sequencing-based analyses have identified gene- and allele-level variation that contribute to the clinically diverse phenotypes observed for many monogenic forms of nephropathy. Genome-wide sequencing studies suggest that dual genetic diagnoses are found in at least 5% of patients in whom a genetic cause of disease is identified, highlighting the fact that complex phenotypes can also arise from multilocus variation. A multifaceted approach that incorporates genetic and phenotypic data from large, diverse cohorts will help to elucidate the complex relationships between genotype and phenotype for different forms of CKD, supporting personalized medicine for individuals with kidney disease.

摘要

虽然慢性肾脏病 (CKD) 通常被认为是一种单一实体疾病,但它实际上包含许多在病理生理学上有明显区别的疾病,这些疾病导致肾脏结构和/或功能持续异常,包括单基因和多基因病因。罕见的遗传性 CKD 形式通常跨越多种表型,反映了包括多效性、不完全外显率和表现度变异在内的遗传现象。使用染色体微阵列和大规模平行测序技术已经表明,基因组疾病和单基因病因对不同临床定义亚组中看似复杂的 CKD 形式有重要贡献,并且具有高度的遗传和表型异质性。对 CKD 中常见基因组疾病的研究综合了遗传、生物信息学和功能研究,以确定其肾脏和肾脏外表现的遗传驱动因素,揭示了单基因和多基因机制。同样,基于大规模平行测序的分析确定了导致许多单基因形式肾病观察到的临床多样化表型的基因和等位基因变异。全基因组测序研究表明,在确定疾病遗传原因的患者中,至少有 5% 存在双重遗传诊断,这突出了一个事实,即复杂的表型也可能源于多基因座变异。一种多方面的方法,将来自大型、多样化队列的遗传和表型数据结合起来,将有助于阐明不同形式的 CKD 中基因型和表型之间的复杂关系,为肾脏病患者的个体化医学提供支持。